Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-29 Sale | 2025-01-31 4:17 pm | Intellia Therapeutics Inc. | NTLA | Bhanji Muna Director | 265 | $9.97 | $2,642 | 19,468 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:23 pm | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, Chief Accounting Officer | 1,372 | $12.18 | $16,711 | 45,640 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:22 pm | Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel | 7,074 | $12.18 | $86,161 | 74,497 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:20 pm | Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer | 9,557 | $12.18 | $116,404 | 87,666 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:20 pm | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 6,502 | $12.18 | $79,194 | 59,878 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:19 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO | 26,807 | $12.18 | $326,509 | 999,530 (Indirect Direct) | View |
| 2025-01-03 Sale | 2025-01-07 5:16 pm | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer | 8,966 | $12.18 | $109,206 | 77,388 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 4:16 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 7,978 | $12.17 | $97,089 | 64,048 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 5:29 pm | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, Chief Accounting Officer | 2,012 | $19.01 | $38,248 | 47,012 (Direct) | View |
| 2024-07-01 Sale | 2024-07-03 1:15 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 405 | $22.93 | $9,287 | 71,470 (Direct) | View |
| 2024-06-17 Sale | 2024-06-20 5:00 pm | Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director | 1,505 | $25 | $37,625 | 17,948 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:10 pm | Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel | 2,297 | $32.99 | $75,778 | 128,323 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:10 pm | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 605 | $32.99 | $19,959 | 116,542 (Direct) | View |
| 2024-01-08 Sale | 2024-01-10 4:15 pm | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer | 2,275 | $28.87 | $65,682 | 43,927 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:51 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO | 19,223 | $29.46 | $566,310 | 904,901 (Indirect Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:50 pm | Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer | 5,843 | $29.46 | $172,135 | 54,372 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:50 pm | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer | 5,532 | $29.46 | $162,973 | 46,202 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:49 pm | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 5,365 | $29.46 | $158,053 | 40,585 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:46 pm | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 3,877 | $29.46 | $114,216 | 36,987 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-01-23 5:41 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Schultes Birgit C EVP, Chief Scientific Officer | 0 | $0 | 249,121 (Direct) | View |
| 2025-01-01 Exercise | 2025-01-03 4:30 pm | 2025-01-01 2031-03-02 | Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer | 3,189 | $0 | 97,223 (Direct) | View |
| 2025-01-01 Exercise | 2025-01-03 4:30 pm | 2025-01-01 2031-03-02 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO | 7,850 | $0 | 1,026,337 (Direct) | View |
| 2025-01-01 Exercise | 2025-01-03 4:30 pm | 2025-01-01 2031-03-02 | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer | 3,500 | $0 | 86,354 (Direct) | View |
| 2024-07-22 Option Award | 2024-07-24 4:17 pm | N/A 2034-07-21 | Intellia Therapeutics Inc. | NTLA | Dulac Edward J III EVP, Chief Financial Officer | 162,543 | $0 | 162,543 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 1:15 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Dube Michael P VP, PAO and Interim PFO | 17,801 | $0 | 49,024 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 5:14 pm | N/A 2034-06-12 | Intellia Therapeutics Inc. | NTLA | Goff Brian Director | 37,706 | $0 | 37,706 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:22 pm | N/A 2034-06-11 | Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director | 19,252 | $0 | 30,968 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:21 pm | N/A 2034-06-11 | Intellia Therapeutics Inc. | NTLA | Keresty Georgia Director | 19,252 | $0 | 35,398 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | N/A 2034-06-11 | Intellia Therapeutics Inc. | NTLA | GOODMAN JESSE Director | 19,252 | $0 | 30,968 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:19 pm | N/A 2034-06-11 | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 19,252 | $0 | 60,968 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:18 pm | N/A 2034-06-11 | Intellia Therapeutics Inc. | NTLA | Bhanji Muna Director | 19,252 | $0 | 31,248 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:16 pm | N/A 2034-06-11 | Intellia Therapeutics Inc. | NTLA | CHASE WILLIAM J Director | 19,252 | $0 | 38,208 (Direct) | View |
Ownership | 2024-04-22 4:10 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Dube Michael P Principal Accounting Officer | 0 | $0 | 31,223 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer | 92,760 | $0 | 136,687 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel | 79,146 | $0 | 128,323 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 71,814 | $0 | 108,801 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Clark Eliana EVP, Chief Technical Officer | 76,302 | $0 | 116,542 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO | 277,515 | $0 | 1,182,416 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer | 94,556 | $0 | 148,928 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer | 69,944 | $0 | 110,529 (Direct) | View |